Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.
Hannah Cock provides insight into the current data, controversies and pipelines for the use of cannabis-derived therapeutics in epilepsy.
Newly published data describe how Eli Lilly’s monoclonal antibody candidate has failed to significantly slow cognitive decline in patients with mild dementia due to Alzheimer’s disease.
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.
Lauren Pulling sat down with Nicole Swann at Neuroscience 2017 to hear more about her work on a novel implantable device capable of delivering adaptive DBS.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
A patient with discomplete spinal injuries has regained limited movement following electrical stimulation treatment and undergoing intensive physical therapy.
Study indicates deep brain stimulation can alleviate the long-term symptoms for patients suffering from treatment-resistant depression.
Christopher S. Ahuja & Michael Fehlings (University of Toronto, ON, Canada) discuss their work in neuroregeneration for spinal cord injuries.